Moderator: Jenny Sauk, MD, UCLA
What’s New and Notable in IBD for 2020, Safety of Therapies in IBD Medication Risk Counseling, Therapeutic Drug Monitoring
PANEL:
Raymond K. Cross, Jr., MD, MS, University of Maryland; Berkeley Limketkai, MD, PhD, UCLA
Mona Rezapour, MD, MHS, UCLA; David T. Rubin, MD, University of Chicago
UCLA Mellinkoff Gastroenterology Symposium March 6-7, 2020
Learn more about the Division of UCLA Digestive Disease at www.uclahealth.org/gastro
Негізгі бет Management of Crohn’s Disease | UCLA Digestive Diseases
Пікірлер: 9